Αποτελέσματα Αναζήτησης
11 Ιουν 2020 · Very cost-effective interventions, based on supportive evidence, were both new findings in this updated review: 1) statin treatment at T2D diagnosis compared with no lipid-regulating treatment ($3,294/QALY) and 2) bariatric surgery for individuals with T2D and overweight compared with no surgery ($23,320/QALY).
11 Ιουν 2020 · We conducted a systematic review of studies evaluating the cost-effectiveness (CE) of interventions to prevent type 2 diabetes (T2D) among high-risk individuals and whole populations.
13 Φεβ 2020 · Article Literature Review. Cost and Cost-Effectiveness of mHealth interventions for the prevention and control of Type 2 Diabetes Mellitus: A Systematic Review. February 2020....
4 Μαΐ 2021 · Key points. Type 2 diabetes mellitus (T2DM) is one of the greatest health crises of our time, and the number of people with T2DM is projected to increase by >50% globally by 2045. Despite our...
We classified the interventions based on their strength of evidence (strong, supportive, or uncertain) and levels of CE: cost-saving (more health benefit at a lower cost), very cost-effective (≤$25,000 per life year gained [LYG] or quality-adjusted life year [QALY]), cost-effective ($25,001-$50,000 per LYG or QALY), marginally cost-effective ($5...
25 Νοε 2016 · Objective: The objective of this study was to conduct a systematic review and meta-analysis of clinical trials, assessing the impact of information technology on changes in the levels of hemoglobin A 1c (HbA 1c) and mapping the interventions with chronic care model (CCM) elements.
Background. Diabetes mellitus affects almost 10% of U.S. adults, leading to human and financial burden. Underserved populations experience a higher risk of diabetes and related complications resulting from a combination of limited disposable income, inadequate diet, and lack of insurance coverage.
